Details for 2013764989

Up to date per 01.04.2026

Actions

Title / Product Name

FORMULIERUNGEN AUS BENDAMUSTIN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2013764989

EP Publication Number

2827862

E-Number

1643893

Language

PCT Number

US13032289

Publication Date

28.01.2015 A

27.12.2023 B1

Registration Date

27.12.2023

AT Publication Date

15.01.2024

Application Date

15.03.2013

Registration Number

Priorities

20.03.2012

201261613173 P

10.07.2012

201261669889 P

IPC

A61K 31/4184 20060101AFI20151014BHEP

Maximum Duration of Protection

15.03.2033

Owner

Eagle Pharmaceuticals, Inc.50 Tice Boulevard Suite 315 Woodcliff Lake, NJ 07677US

Representative

Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT

Inventor

SUNDARAM, Srikanth138 Emerson Road Somerset, New Jersey 08873US

Information about Fees